Patents Assigned to ONCODESIGN PRECISION MEDICINE
  • Macrocyclic LRRK2 kinase inhibitors
    Patent number: 12545689
    Abstract: Compounds of Formula (I): wherein R, X1, X2, X3, Z1, Z2, Z3, A and Ra are as defined in the description.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: February 10, 2026
    Assignee: ONCODESIGN PRECISION MEDICINE
    Inventors: Petra Marcella Blom, Christopher Gaétan Housseman, Alain Daugan, Audrey Dumoulin, Maxime Laugeois, Alexis Denis, Nicolas Faucher, Iuliana Botez, Arnaud Le Tiran, Kenneth Christensen, Yann Lamotte